Protecting long-term care patients from antibiotic resistant infections: ethics, cost-effectiveness, and reimbursement issues.
Farr
B M
BM
D000368:Aged; D003362:Cost-Benefit Analysis; D003428:Cross Infection / Q000191:economics / Q000517:prevention & control*; D016983:Enterococcus; D004992:Ethics, Medical; D016908:Gram-Positive Bacterial Infections / Q000191:economics / Q000517:prevention & control*; D006801:Humans; D017053:Infection Control / Q000379:methods*; D008134:Long-Term Care / Q000379:methods*; D012051:Reimbursement Mechanisms / Q000191:economics*; D012866:Skilled Nursing Facilities / Q000191:economics; D020713:Vancomycin Resistance